MedPath

Prospective study for the effects of pancreatic enzyme replacement therapy on quality of life and nutritional assessment after pancreas resectio

Not Applicable
Recruiting
Conditions
Diseases of the digestive system
Registration Number
KCT0000010
Lead Sponsor
Seoul National University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
232
Inclusion Criteria

Patients who underwent pancreatectomy (pancreatoduodenectomy, pylorus-preserving pancreatoduodenectomy, distal pancreatectomy, spleen-preserving distal panreatectomy, subtotal pancreatectomy)
- Patients who can be regulary followed-up for at least 1 year
- Informed consent

Exclusion Criteria

- Noncurative resection
- Recurrence or distat metastasis
- Severe comorbidity (cardiovascular, pulmonary, renal, neurologic)
- Other abdominal surgery which can have impact on quality of life (ex. gastrectomy, colectomy)
- Patients who cannot understand the study

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
quality of life
Secondary Outcome Measures
NameTimeMethod
Glucose intolerance;Nutritional status;Pancreatic exocrine insufficiency;Remnant pancreas atrophy
© Copyright 2025. All Rights Reserved by MedPath